Athersys, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ATHX Nasdaq 2834 http://www.athersys.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Athersys, Inc.

Free Technical Reports on Arrowhead Pharma and Three Additional Biotech Equities - Jun 13th, 2018 5:05 am
Benzinga Pro's 5 Stocks To Watch Today - Jun 7th, 2018 6:41 am
Athersys Announces Expansion of Collaboration With Healios - Jun 7th, 2018 4:00 am
Edited Transcript of ATHX earnings conference call or presentation 10-May-18 8:30pm GMT - Jun 6th, 2018 2:07 pm
The Zacks Analyst Blog Highlights: Illumina, Athersys, EyePoint Pharmaceuticals, Rhythm Pharmaceuticals and Ligand Pharmaceuticals - Jun 4th, 2018 7:41 am
"Right To Try" Brings Good News for Biotech Sector: 5 Picks - Jun 1st, 2018 6:42 am
5 Biotech Stocks to Boost Your Portfolio’s Health This Year - May 31st, 2018 9:23 am
5 Biotech Stocks to Boost Your Portfolio's Health This Year - May 31st, 2018 6:04 am
BioMarin's Palynziq Gets FDA Approval for Phenylketonuria - May 25th, 2018 8:57 am
INSYS Gets Negative FDA Recommendation for Pain Candidate - May 23rd, 2018 8:22 am
Moving Average Crossover Alert: Athersys, Inc. (ATHX) - May 22nd, 2018 5:24 am
Athersys Reports First Quarter 2018 Results - May 10th, 2018 2:03 pm
Athersys Inc (NASDAQ:ATHX): Should The Recent Earnings Drop Worry You? - May 10th, 2018 10:11 am
Athersys and Healios Extend by One Month the Period to Complete Collaboration Expansion Agreements - May 1st, 2018 4:00 am
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Breaches of Delaware Law by the Board of Athersys, Inc. -- ATHX - Apr 27th, 2018 7:45 am
Recent Analysis Shows First Cash, ADTRAN, OMNOVA Solutions, Athersys, Oppenheimer, and Conn's Market Influences — Renewed Outlook, Key Drivers of Growth - Apr 25th, 2018 5:50 am
UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients - Apr 23rd, 2018 4:00 am
Athersys to Host First Quarter Financial Results Call - Apr 12th, 2018 2:00 pm
Edited Transcript of ATHX conference call or presentation 28-Jul-10 8:30pm GMT - Apr 11th, 2018 12:56 am